• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝硬化慢性肝性脑病的饮食方法与肠道微生物群调节

Dietary approach and gut microbiota modulation for chronic hepatic encephalopathy in cirrhosis.

作者信息

Campion Daniela, Giovo Ilaria, Ponzo Paola, Saracco Giorgio M, Balzola Federico, Alessandria Carlo

机构信息

Division of Gastroenterology and Hepatology, Città della Salute e della Scienza di Torino Hospital, University of Turin, 10126 Turin, Italy.

出版信息

World J Hepatol. 2019 Jun 27;11(6):489-512. doi: 10.4254/wjh.v11.i6.489.

DOI:10.4254/wjh.v11.i6.489
PMID:31293718
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6603507/
Abstract

Hepatic encephalopathy (HE) is a common and serious neuropsychiatric complication of cirrhosis, acute liver failure, and porto-systemic shunting. HE largely contributes to the morbidity of patients with liver disease, severely affecting the quality of life of both patients and their relatives and being associated with poor prognosis. Its presentation is largely variable, manifesting with a broad spectrum of cognitive abnormalities ranging from subtle cognitive impairment to coma. The pathogenesis of HE is complex and has historically been linked with hyperammonemia. However, in the last years, it has become evident that the interplay of multiple actors, such as intestinal dysbiosis, gut hyperpermeability, and neuroinflammation, is of crucial importance in its genesis. Therefore, HE can be considered a result of a dysregulated gut-liver-brain axis function, where cognitive impairment can be reversed or prevented by the beneficial effects induced by "gut-centric" therapies, such as non-absorbable disaccharides, non-absorbable antibiotics, probiotics, prebiotics, and fecal microbiota transplantation. In this context dietary modifications, by modulating the intestinal milieu, can also provide significant benefit to cirrhotic patients with HE. This review will provide a comprehensive insight into the mechanisms responsible for gut-liver-brain axis dysregulation leading to HE in cirrhosis. Furthermore, it will explore the currently available therapies and the most promising future treatments for the management of patients with HE, with a special focus on the dietary approach.

摘要

肝性脑病(HE)是肝硬化、急性肝衰竭和门体分流常见且严重的神经精神并发症。HE在很大程度上导致了肝病患者的发病,严重影响患者及其亲属的生活质量,并与不良预后相关。其表现差异很大,表现为从轻微认知障碍到昏迷的广泛认知异常。HE的发病机制复杂,历史上一直与高氨血症有关。然而,近年来,很明显,多种因素的相互作用,如肠道菌群失调、肠道通透性增加和神经炎症,在其发病过程中至关重要。因此,HE可被视为肠-肝-脑轴功能失调的结果,其中认知障碍可通过“以肠道为中心”的疗法(如不可吸收的二糖、不可吸收的抗生素、益生菌、益生元及粪便微生物群移植)诱导的有益作用得到逆转或预防。在此背景下,通过调节肠道环境,饮食调整也可为肝硬化合并HE的患者带来显著益处。本综述将全面深入探讨导致肝硬化患者发生HE的肠-肝-脑轴失调的机制。此外,还将探讨目前可用的治疗方法以及治疗HE患者最有前景的未来疗法,特别关注饮食方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8704/6603507/96b45abc822c/WJH-11-489-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8704/6603507/20b367bf347d/WJH-11-489-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8704/6603507/b1cebb5bb121/WJH-11-489-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8704/6603507/96b45abc822c/WJH-11-489-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8704/6603507/20b367bf347d/WJH-11-489-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8704/6603507/b1cebb5bb121/WJH-11-489-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8704/6603507/96b45abc822c/WJH-11-489-g003.jpg

相似文献

1
Dietary approach and gut microbiota modulation for chronic hepatic encephalopathy in cirrhosis.肝硬化慢性肝性脑病的饮食方法与肠道微生物群调节
World J Hepatol. 2019 Jun 27;11(6):489-512. doi: 10.4254/wjh.v11.i6.489.
2
The Link between Gut Microbiota and Hepatic Encephalopathy.肠道微生物群与肝性脑病的关系。
Int J Mol Sci. 2022 Aug 12;23(16):8999. doi: 10.3390/ijms23168999.
3
The pathogenesis of gut microbiota in hepatic encephalopathy by the gut-liver-brain axis.肝性脑病通过肠-肝-脑轴的肠道微生物组发病机制。
Biosci Rep. 2023 Jun 28;43(6). doi: 10.1042/BSR20222524.
4
Role of gut microbiota in the pathogenesis and therapeutics of minimal hepatic encephalopathy the gut-liver-brain axis.肠道微生物群在轻微型肝性脑病发病机制和治疗中的作用——肠道-肝脏-大脑轴。
World J Gastroenterol. 2023 Jan 7;29(1):144-156. doi: 10.3748/wjg.v29.i1.144.
5
[Correction of gut dysbiosis as a promising direction in the prevention of neuroinflammation and cognitive impairment].纠正肠道菌群失调作为预防神经炎症和认知障碍的一个有前景的方向
Vopr Pitan. 2023;92(6):107-119. doi: 10.33029/0042-8833-2023-92-6-107-119. Epub 2023 Oct 30.
6
Prevention and treatment of hepatic encephalopathy: focusing on gut microbiota.肝性脑病的防治:关注肠道微生物群。
World J Gastroenterol. 2012 Dec 14;18(46):6693-700. doi: 10.3748/wjg.v18.i46.6693.
7
Gut Dysbiosis and Blood-Brain Barrier Alteration in Hepatic Encephalopathy: From Gut to Brain.肝性脑病中的肠道菌群失调与血脑屏障改变:从肠道到大脑
Biomedicines. 2023 Apr 25;11(5):1272. doi: 10.3390/biomedicines11051272.
8
Nonpharmacologic Management of Hepatic Encephalopathy: An Update.非药物治疗肝性脑病:更新。
Clin Liver Dis. 2020 May;24(2):243-261. doi: 10.1016/j.cld.2020.01.003. Epub 2020 Feb 26.
9
Gut Microbiota and Neuroinflammation in Acute Liver Failure and Chronic Liver Disease.急性肝衰竭和慢性肝病中的肠道微生物群与神经炎症
Metabolites. 2023 Jun 20;13(6):772. doi: 10.3390/metabo13060772.
10
Pharmacotherapy for hepatic encephalopathy.肝性脑病的药物治疗。
Drugs. 2010 Jun 18;70(9):1131-48. doi: 10.2165/10898630-000000000-00000.

引用本文的文献

1
Unraveling the Gut-Liver-Brain Axis: Microbiome, Inflammation, and Emerging Therapeutic Approaches.解析肠-肝-脑轴:微生物群、炎症及新兴治疗方法
Mediators Inflamm. 2025 Jun 18;2025:6733477. doi: 10.1155/mi/6733477. eCollection 2025.
2
A Comprehensive Review of the Usefulness of Prebiotics, Probiotics, and Postbiotics in the Diagnosis and Treatment of Small Intestine Bacterial Overgrowth.益生元、益生菌和后生元在小肠细菌过度生长诊断与治疗中应用价值的全面综述
Microorganisms. 2025 Jan 1;13(1):57. doi: 10.3390/microorganisms13010057.
3
Li-Hong Tang alleviates dextran sodium sulfate-induced colitis by regulating NRF2/HO-1 signaling pathway and gut microbiota.

本文引用的文献

1
HLA-DQ Genotyping, Duodenal Histology, and Response to Exclusion Diet in Autistic Children With Gastrointestinal Symptoms.HLA-DQ 基因分型、十二指肠组织学和排除饮食对有胃肠道症状自闭症儿童的反应。
J Pediatr Gastroenterol Nutr. 2019 Jul;69(1):39-44. doi: 10.1097/MPG.0000000000002293.
2
Sarcopenia: Ammonia metabolism and hepatic encephalopathy.肌肉减少症:氨代谢与肝性脑病。
Clin Mol Hepatol. 2019 Sep;25(3):270-279. doi: 10.3350/cmh.2019.0015. Epub 2019 Apr 22.
3
Assessment and Management of Nutrition Status in the Hospitalized Patient With Cirrhosis.
唐立宏通过调节NRF2/HO-1信号通路和肠道微生物群来减轻葡聚糖硫酸钠诱导的结肠炎。
Front Pharmacol. 2024 May 30;15:1413666. doi: 10.3389/fphar.2024.1413666. eCollection 2024.
4
Does Gut Microbiome have an Effect on Wilson's Disease Phenotype?肠道微生物群对威尔逊病的表型有影响吗?
Curr Med Chem. 2025;32(4):825-829. doi: 10.2174/0109298673282452240122103156.
5
Liver cirrhosis and complications from the perspective of dysbiosis.从菌群失调角度看肝硬化及其并发症
Front Med (Lausanne). 2024 Jan 16;10:1320015. doi: 10.3389/fmed.2023.1320015. eCollection 2023.
6
Gut commensals and their metabolites in health and disease.健康与疾病中的肠道共生菌及其代谢产物
Front Microbiol. 2023 Nov 8;14:1244293. doi: 10.3389/fmicb.2023.1244293. eCollection 2023.
7
Treating Leaky Syndrome in the Over 65s: Progress and Challenges.治疗 65 岁以上人群的渗漏综合征:进展与挑战。
Clin Interv Aging. 2023 Aug 31;18:1447-1451. doi: 10.2147/CIA.S409801. eCollection 2023.
8
Gut Microbiota and Neuroinflammation in Acute Liver Failure and Chronic Liver Disease.急性肝衰竭和慢性肝病中的肠道微生物群与神经炎症
Metabolites. 2023 Jun 20;13(6):772. doi: 10.3390/metabo13060772.
9
The pathogenesis of gut microbiota in hepatic encephalopathy by the gut-liver-brain axis.肝性脑病通过肠-肝-脑轴的肠道微生物组发病机制。
Biosci Rep. 2023 Jun 28;43(6). doi: 10.1042/BSR20222524.
10
Yeast Cell Wall Compounds on The Formation of Fermentation Products and Fecal Microbiota in Cats: An In Vivo and In Vitro Approach.酵母细胞壁化合物对猫发酵产物形成和粪便微生物群的影响:体内和体外研究方法
Animals (Basel). 2023 Feb 11;13(4):637. doi: 10.3390/ani13040637.
肝硬化住院患者营养状况的评估与管理
Clin Liver Dis (Hoboken). 2018 Nov 6;12(4):113-116. doi: 10.1002/cld.758. eCollection 2018 Oct.
4
Late evening snacks with branched-chain amino acids improve the Fischer ratio with patients liver cirrhosis at fasting in the next morning.晚间食用含支链氨基酸的零食可提高肝硬化患者次日清晨空腹时的费希尔比率。
Clin Nutr ESPEN. 2019 Apr;30:138-144. doi: 10.1016/j.clnesp.2019.01.003. Epub 2019 Jan 24.
5
Significant effects of late evening snack on liver functions in patients with liver cirrhosis: A meta-analysis of randomized controlled trials.深夜小吃对肝硬化患者肝功能的显著影响:一项随机对照试验的荟萃分析。
J Gastroenterol Hepatol. 2019 Jul;34(7):1143-1152. doi: 10.1111/jgh.14665. Epub 2019 May 7.
6
Peripheral inflammation induces neuroinflammation that alters neurotransmission and cognitive and motor function in hepatic encephalopathy: Underlying mechanisms and therapeutic implications.外周炎症引起神经炎症,改变肝性脑病的神经递质传递和认知及运动功能:潜在机制和治疗意义。
Acta Physiol (Oxf). 2019 Jun;226(2):e13270. doi: 10.1111/apha.13270. Epub 2019 Mar 22.
7
Hepatic encephalopathy: Lessons from preclinical studies.肝性脑病:临床前研究的经验教训。
World J Hepatol. 2019 Feb 27;11(2):173-185. doi: 10.4254/wjh.v11.i2.173.
8
Specific Gut and Salivary Microbiota Patterns Are Linked With Different Cognitive Testing Strategies in Minimal Hepatic Encephalopathy.特定的肠道和唾液微生物群模式与轻微肝性脑病中不同的认知测试策略相关。
Am J Gastroenterol. 2019 Jul;114(7):1080-1090. doi: 10.14309/ajg.0000000000000102.
9
Hepatic Encephalopathy and Sarcopenia: Two Faces of the Same Metabolic Alteration.肝性脑病与肌肉减少症:同一代谢改变的两面
J Clin Exp Hepatol. 2019 Jan-Feb;9(1):125-130. doi: 10.1016/j.jceh.2018.04.007. Epub 2018 May 5.
10
ESPEN guideline on clinical nutrition in liver disease.ESPEN 临床肝病营养指南。
Clin Nutr. 2019 Apr;38(2):485-521. doi: 10.1016/j.clnu.2018.12.022. Epub 2019 Jan 16.